Our Clinical Trials
The Sean N. Parker Center for Allergy & Asthma Research at Stanford University conducts many clinical trials with the goal of developing therapies for allergic disorders. Please visit www.clinicaltrials.gov to learn more about the clinical trials offered at our Center.
Hear from our clinical trial patients
14 year-old Megan says, "It has been life-changing to not have to worry about having a severe allergic reaction every time I am around food.” She is desensitized to all four of her food allergens and no longer needs to worry about cross-contamination.
When the news came of Carter’s acceptance into the Center’s multi-allergen oral immunotherapy trial with Xolair, Darren knew he would do whatever it took to make his wife’s vision for their son a reality.
“A big thank you to everyone!” 8 year-old Maya would like to tell Dr. Nadeau and her entire staff for their care during her food allergy trial.
16 year-old Matthew emphatically says "I am living proof that the future is extremely bright for people with food allergies. My family and I never imagined I would live a carefree life free from the fear of cross contamination. Being able to sit with my friends and eat a normal meal in a restaurant is really a huge bonus."
In 2010, we heard about Dr. Kari Nadeau’s food allergy research at Stanford. We had read about early work in oral immunotherapy (OIT), and were beyond excited to find out that cutting-edge research was being conducted in the San Francisco Bay Area.
As an adult living his entire life with a peanut allergy, Dan never imagined that there would be a day when he would be able to eat a peanut safely.
Under the leadership of Kari Nadeau, MD, PhD, our Center has treated more than 700 patients over the last three years. Read a sampling of answers to the question: how has your life changed since completing an allergy trial at Stanford?
Our studies include a wide range of patients, representing a diverse group of ages, ethnicities and socioeconomic backgrounds. Our Center offers equal opportunity to all people with allergies, so long as they are eligible based on study parameters.
Courtesy of Food Allergy Research & Education (FARE)